Immunotherapy Co. Hits Ch. 11 With $21M In Debt
Immunotherapy lab Argos Therapeutics Inc. on Friday filed for Chapter 11 in Delaware bankruptcy court with $21 million in debt, and plans to sell its business to a buyer-in-waiting for roughly...To view the full article, register now.
Already a subscriber? Click here to view full article